Related Experiment Video
Updated: Mar 24, 2026
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
A mathematical model verifying potent oncolytic efficacy of M1 virus
Zizi Wang1, Zhiming Guo1, Huaqin Peng1
1School of Mathematics and Information Science, Guangzhou University, Guangzhou 510006, PR China; Key Laboratory of Mathematics and Interdisciplinary Science of Guangdong, Higher Education Institutes, Guangzhou University, Guangzhou 510006, PR China.
Abstract:
Motivated by the latest findings in a recent medical experiment [19] which identify a naturally occurring alphavirus (M1) as a novel selective killer targeting zinc-finger antiviral protein (ZAP)-deficient cancer cells, we propose a mathematical model to illustrate the growth of normal cells, tumor cells and the M1 virus with limited nutrient. In order to better understand biological mechanisms, we discuss two cases of the model: without competition and with competition. In the first part, the explicit threshold conditions for the persistence of normal cells (or tumor cells) is obtained accompanying with the biological explanations. The second part indicates that when competing with tumor cells, the normal cells will extinct if M1 virus is ignored; Whereas, when M1 virus is considered, the growth trend of normal cells is similar to the one without competition. And by using uniformly strong repeller theorem, the minimum effective dosage of medication is explicitly found which is not reported in [19]. Furthermore, numerical simulations and corresponding biological interpretations are given to support our results.
Insights
A novel alphavirus (M1) selectively targets cancer cells lacking zinc-finger antiviral protein (ZAP). Mathematical modeling reveals M1 virus influences normal cell survival and identifies minimum effective dosage for potential cancer therapies.
Area of Science:
- Virology
- Mathematical Biology
- Oncology
Background:
- Recent findings identify a naturally occurring alphavirus (M1) as a selective killer of zinc-finger antiviral protein (ZAP)-deficient cancer cells.
- Understanding the dynamics of M1 virus interaction with normal and tumor cells is crucial for therapeutic development.
Purpose of the Study:
- To develop a mathematical model simulating the growth of normal cells, tumor cells, and M1 virus under nutrient limitation.
- To analyze the impact of M1 virus on normal cell survival in the presence and absence of tumor cell competition.
- To determine the minimum effective dosage of M1 virus for therapeutic intervention.
Main Methods:
- Development of a mathematical model incorporating normal cells, tumor cells, and M1 virus dynamics.
- Analysis of two cases: without and with inter-species competition.
- Application of the uniformly strong repeller theorem to find minimum effective dosage.
- Numerical simulations to validate model predictions.
Main Results:
- Explicit threshold conditions for normal and tumor cell persistence were derived.
- Without M1 virus consideration, normal cells extinct when competing with tumor cells.
- M1 virus presence promotes normal cell survival, similar to scenarios without competition.
- The minimum effective dosage of M1 virus was explicitly calculated.
Conclusions:
- The mathematical model provides insights into M1 virus-cancer cell interactions.
- M1 virus plays a significant role in modulating normal cell dynamics during tumor progression.
- The study identifies a quantifiable therapeutic window for M1 virus-based cancer treatments.
